CACCIAPAGLIA, FABIO
CACCIAPAGLIA, FABIO
Dipartimento di Medicina e Chirurgia
A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis
2019-01-01 Venerito, V; Lopalco, G; Cacciapaglia, F; Fornaro, M; Iannone, F
A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents
2022-01-01 Venerito, V; Angelini, O; Fornaro, M; Cacciapaglia, F; Lopalco, G; Iannone, F.
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases
2022-01-01 Ferri, C; Gragnani, L; Raimondo, V; Visentini, M; Giuggioli, D; Lorini, S; Foti, R; Cacciapaglia, F; Et, Al.
Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors
2009-01-01 Vadacca, M; Margiotta, D; Rigon, A; Cacciapaglia, F; Coppolino, G; Amoroso, A; Afeltra, A
Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels
2006-01-01 Bruni, R; Serino, Fm; Galluzzo, S; Coppolino, G; Cacciapaglia, F; Vadacca, M; Nilo, S; Terminio, N; Afeltra, A
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE)
2017-01-01 Ceccarelli, F; Massafra, U; Perricone, C; Idolazzi, L; Giacomelli, R; Tirri, R; Russo, R; Pistone, G; Ruscitti, P; Parisi, S; Sainaghi, Pp; Cacciapaglia, F; Zullo, A; Marino, V; Migliore, A; Valesini, G
Antinuclear antibodies prevalence in Filipinos migrated to Italy
2008-01-01 Cacciapaglia, F; Arcarese, L; Rigon, A; Vadacca, M; Valorani, Mg; Pozzilli, P; Afeltra, A
APOPTOSIS AND AUTOIMMUNITY INDUCED BY CLODRONATE IN SYSTEMIC LUPUS ERYTHEMATOSUS MONONUCLEAR CIRCULATING CELLS
2010-01-01 Cacciapaglia, F; Spadaccio, C; Gregorj, C; Margiotta, D; Coccia, R; De Marco, F; Chello, M; Picardi, A; Amoroso, A; Afeltra, A
Apoptotic molecular mechanisms implicated in autoimmune diseases
2009-01-01 Cacciapaglia, F; Spadaccio, C; Chello, M; Gigante, A; Coccia, R; Afeltra, A; Amoroso, A
Atherosclerosis and Autoimmunity
2018-01-01 Spinelli, Fr; Barone, F; Cacciapaglia, F; Pecani, A; Piga, M
Body mass index and adipokines/cytokines dysregulation in systemic sclerosis
2021-01-01 Iannone, F; Praino, E; Rotondo, C; Natuzzi, D; Bizzoca, R; Lacarpia, N; Fornaro, M; Cacciapaglia, F
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group.
2021-01-01 Ursini, F; Ruscitti, P; D'Angelo, S; Cacciapaglia, F; De Angelis, R; Campochiaro, C; Caso, F; De Santis, M; Di Cola, I; Parisi, S; Raimondo, V; Abignano, G; Costa, L; Ciaffi, J; Dagna, L; Iagnocco, A; Iannone, F; Meliconi, R; Giacomelli, R; Ferri, C.
C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis
2022-01-01 Erre, Gl; Cacciapaglia, F; Sakellariou, G; Manfredi, A; Bartoloni, E; Viapiana, O; Fornaro, M; Cauli, A; Mangoni, Aa; Woodman, Rj; Palermo, Bl; Gremese, E; Cafaro, G; Nucera, V; Vacchi, C; Spinelli, Fr; Atzeni, F; Piga, M; “Cardiovascular, ; Obesity and Rheumatic Disease Study (CORDIS) Group” of the Italian Society of Rheumatology, (SIR).
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis
2020-01-01 Cacciapaglia, F; Fornaro, M; Venerito, V; Perniola, S; Urso, L; Iannone, F.
Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues
2011-01-01 Cacciapaglia, F; Navarini, L; Menna, P; Salvatorelli, E; Minotti, G; Afeltra, A
Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis
2020-01-01 Iannone, F; Nivuori, M; Fornaro, M; Venerito, V; Cacciapaglia, F; Lopalco, G.
Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis
2022-01-01 Cacciapaglia, F; Venerito, V; Stano, S; Fornaro, M; Lopalco, G; Iannone, F.
Complete Hydatidiform Mole Mimicking Sacroiliitis
2021-01-01 Arezzo, F; Venerito, V; Fornaro, M; Cacciapaglia, F; Lopalco, G; Iannone, F.
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients
2020-01-01 Cacciapaglia, F; Manfredi, A; Erre, G; Piga, M; Sakellariou, G; Viapiana, O; Gremese, E; Spinelli, Fr; Atzeni, F; Bartoloni, E.
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments.
2021-01-01 Ferri, C; Giuggioli, D; Raimondo, V; L'Andolina, M; Dagna, L; Tavoni, A; Caso, F; Ursini, F; Piero, R; Caminiti, M; Foti, R; Riccieri, V; Guiducci, S; Pellegrini, R; Zanatta, E; Varcasia, G; Olivo, D; Gigliotti, P; Cuomo, G; Murdaca, G; Cecchetti, R; De Angelis, R; Romeo, N; Ingegnoli, F; Cozzi, F; Codullo, V; Cavazzana, I; Colaci, M; Abignano, G; De Santis, M; Lubrano, E; Fusaro, E; Rossa, Ad; Spinella, A; Lumetti, F; De Luca, G; Bellando-Randone, S; Visalli, E; Dal Bosco, Y; Amato, G; Giannini, D; Bilia, S; Masini, F; Pellegrino, G; Pigatto, E; Generali, E; Mariano, Gp; Pettiti, G; Zanframundo, G; Brittelli, R; Aiello, V; Caminiti, R; Scorpiniti, D; Ferrari, T; Campochiaro, C; Brusi, V; Fredi, M; Moschetti, L; Cacciapaglia, F; Gragnani, L; Monti, M; Lorini, S; Paparo, Sr; Ragusa, F; Mazzi, V; Elia, G; Ferrari, Sm; Di Cola, I; Vadacca, M; Lorusso, S; Barsotti, S; Aprile, Ml; Marco, T; Miccoli, M; Bosello, S; Matucci-Cerinic, M; D'Angelo, S; Doria, A; Franceschini, F; Meliconi, R; Iannone, F; Giacomelli, R; Zignego, Al; Varcasia, P; Antonelli, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis | 1-gen-2019 | Venerito, V; Lopalco, G; Cacciapaglia, F; Fornaro, M; Iannone, F | |
| A Machine Learning Approach for Predicting Sustained Remission in Rheumatoid Arthritis Patients on Biologic Agents | 1-gen-2022 | Venerito, V; Angelini, O; Fornaro, M; Cacciapaglia, F; Lopalco, G; Iannone, F. | |
| Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases | 1-gen-2022 | Ferri, C; Gragnani, L; Raimondo, V; Visentini, M; Giuggioli, D; Lorini, S; Foti, R; Cacciapaglia, F; Et, Al. | |
| Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors | 1-gen-2009 | Vadacca, M; Margiotta, D; Rigon, A; Cacciapaglia, F; Coppolino, G; Amoroso, A; Afeltra, A | |
| Alexithymia and neuroendocrine-immune response in patients with autoimmune diseases: preliminary results on relationship between alexithymic construct and TNF-alpha levels | 1-gen-2006 | Bruni, R; Serino, Fm; Galluzzo, S; Coppolino, G; Cacciapaglia, F; Vadacca, M; Nilo, S; Terminio, N; Afeltra, A | |
| Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) | 1-gen-2017 | Ceccarelli, F; Massafra, U; Perricone, C; Idolazzi, L; Giacomelli, R; Tirri, R; Russo, R; Pistone, G; Ruscitti, P; Parisi, S; Sainaghi, Pp; Cacciapaglia, F; Zullo, A; Marino, V; Migliore, A; Valesini, G | |
| Antinuclear antibodies prevalence in Filipinos migrated to Italy | 1-gen-2008 | Cacciapaglia, F; Arcarese, L; Rigon, A; Vadacca, M; Valorani, Mg; Pozzilli, P; Afeltra, A | |
| APOPTOSIS AND AUTOIMMUNITY INDUCED BY CLODRONATE IN SYSTEMIC LUPUS ERYTHEMATOSUS MONONUCLEAR CIRCULATING CELLS | 1-gen-2010 | Cacciapaglia, F; Spadaccio, C; Gregorj, C; Margiotta, D; Coccia, R; De Marco, F; Chello, M; Picardi, A; Amoroso, A; Afeltra, A | |
| Apoptotic molecular mechanisms implicated in autoimmune diseases | 1-gen-2009 | Cacciapaglia, F; Spadaccio, C; Chello, M; Gigante, A; Coccia, R; Afeltra, A; Amoroso, A | |
| Atherosclerosis and Autoimmunity | 1-gen-2018 | Spinelli, Fr; Barone, F; Cacciapaglia, F; Pecani, A; Piga, M | |
| Body mass index and adipokines/cytokines dysregulation in systemic sclerosis | 1-gen-2021 | Iannone, F; Praino, E; Rotondo, C; Natuzzi, D; Bizzoca, R; Lacarpia, N; Fornaro, M; Cacciapaglia, F | |
| Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. | 1-gen-2021 | Ursini, F; Ruscitti, P; D'Angelo, S; Cacciapaglia, F; De Angelis, R; Campochiaro, C; Caso, F; De Santis, M; Di Cola, I; Parisi, S; Raimondo, V; Abignano, G; Costa, L; Ciaffi, J; Dagna, L; Iagnocco, A; Iannone, F; Meliconi, R; Giacomelli, R; Ferri, C. | |
| C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis | 1-gen-2022 | Erre, Gl; Cacciapaglia, F; Sakellariou, G; Manfredi, A; Bartoloni, E; Viapiana, O; Fornaro, M; Cauli, A; Mangoni, Aa; Woodman, Rj; Palermo, Bl; Gremese, E; Cafaro, G; Nucera, V; Vacchi, C; Spinelli, Fr; Atzeni, F; Piga, M; “Cardiovascular, ; Obesity and Rheumatic Disease Study (CORDIS) Group” of the Italian Society of Rheumatology, (SIR). | |
| Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis | 1-gen-2020 | Cacciapaglia, F; Fornaro, M; Venerito, V; Perniola, S; Urso, L; Iannone, F. | |
| Cardiovascular safety of anti-TNF-alpha therapies: Facts and unsettled issues | 1-gen-2011 | Cacciapaglia, F; Navarini, L; Menna, P; Salvatorelli, E; Minotti, G; Afeltra, A | |
| Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis | 1-gen-2020 | Iannone, F; Nivuori, M; Fornaro, M; Venerito, V; Cacciapaglia, F; Lopalco, G. | |
| Comparison of Adalimumab to Other Targeted Therapies in Rheumatoid Arthritis: Results from Systematic Literature Review and Meta-Analysis | 1-gen-2022 | Cacciapaglia, F; Venerito, V; Stano, S; Fornaro, M; Lopalco, G; Iannone, F. | |
| Complete Hydatidiform Mole Mimicking Sacroiliitis | 1-gen-2021 | Arezzo, F; Venerito, V; Fornaro, M; Cacciapaglia, F; Lopalco, G; Iannone, F. | |
| Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al. The impact of cardiovascular comorbidity on COVID-19 infection in a large cohort of rheumatoid arthritis patients | 1-gen-2020 | Cacciapaglia, F; Manfredi, A; Erre, G; Piga, M; Sakellariou, G; Viapiana, O; Gremese, E; Spinelli, Fr; Atzeni, F; Bartoloni, E. | |
| Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments. | 1-gen-2021 | Ferri, C; Giuggioli, D; Raimondo, V; L'Andolina, M; Dagna, L; Tavoni, A; Caso, F; Ursini, F; Piero, R; Caminiti, M; Foti, R; Riccieri, V; Guiducci, S; Pellegrini, R; Zanatta, E; Varcasia, G; Olivo, D; Gigliotti, P; Cuomo, G; Murdaca, G; Cecchetti, R; De Angelis, R; Romeo, N; Ingegnoli, F; Cozzi, F; Codullo, V; Cavazzana, I; Colaci, M; Abignano, G; De Santis, M; Lubrano, E; Fusaro, E; Rossa, Ad; Spinella, A; Lumetti, F; De Luca, G; Bellando-Randone, S; Visalli, E; Dal Bosco, Y; Amato, G; Giannini, D; Bilia, S; Masini, F; Pellegrino, G; Pigatto, E; Generali, E; Mariano, Gp; Pettiti, G; Zanframundo, G; Brittelli, R; Aiello, V; Caminiti, R; Scorpiniti, D; Ferrari, T; Campochiaro, C; Brusi, V; Fredi, M; Moschetti, L; Cacciapaglia, F; Gragnani, L; Monti, M; Lorini, S; Paparo, Sr; Ragusa, F; Mazzi, V; Elia, G; Ferrari, Sm; Di Cola, I; Vadacca, M; Lorusso, S; Barsotti, S; Aprile, Ml; Marco, T; Miccoli, M; Bosello, S; Matucci-Cerinic, M; D'Angelo, S; Doria, A; Franceschini, F; Meliconi, R; Iannone, F; Giacomelli, R; Zignego, Al; Varcasia, P; Antonelli, A. |